Anthony Fernandez, MD, PhD

Anthony Fernandez, MD, PhD

Department Dermatology
Primary Location Cleveland Clinic Main Campus
Type of Doctor Both Adults and Children & Adolescents
Languages English
Surgeon No
Locations Specialties & Treatments

Treatment & Services

  • Dermatopathology
  • Excisions
  • General Dermatology
  • Phototherapy
  • Skin Biopsies
  • Skin Examinations
View all 6 Treatment & Services +

Specialty in Diseases & Conditions

  • Acne
  • Adult Dermatology
  • Alopecia Areata
  • Atypcial Nevi
  • Autoimmune Blistering Diseases
  • Blisters
  • Cellulitis
  • Cold Sores
  • Connective Tissue Disorders
  • Cutaneous Ulcers
  • Dermatitis
  • Dermatitis - Contact
  • Dermatomyositis
  • Dry Skin/Itchy Skin
  • Eczema
  • Fungal Infections
  • Genital Warts
  • Herpes
  • Hives (Urticaria)
  • Kaposi Sarcoma (ks)
  • Lupus
  • Lyme Disease
  • Lymphedema
  • Moles
  • Molluscum Contagiosum
  • Panniculitis
  • Pemphigoid
  • Pemphigus
  • Perioral Dermatitis
  • Polyarteritis Nodosa
  • Porphyria
  • Psoriasis
  • Pyoderma Gangrenosum
  • Ringworm
  • Rosacea (Adult Acne)
  • Sarcoidosis
  • Scabies
  • Scleroderma
  • Sezary Syndrome
  • Shingles (Varicella-Zoster Virus)
  • Skin Cancer
  • Sunburn
  • The Poison Plants: Poison Ivy, Poison Oak and Poison Sumac
  • Tick Bites
  • Toenail Fungus
  • Vasculitis
  • Venous Insufficiency
  • Venous Leg Ulcers
  • Vitiligo
  • Warts
  • Yeast Infections
View all 51 Specialties +
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About Anthony Fernandez, MD, PhD

Dr. Fernandez completed his dermatology residency at the University of Miami, Florida and a dermatopathology fellowship at the Cleveland Clinic.  He currently practices both medical dermatology and dermatopathology and serves as Director of medical and inpatient dermatology.  Clinically, he specializes in treatment of systemic autoimmune and inflammatory diseases with prominent cutaneous involvement.  His research interests mirror his clinical interests, with ongoing projects involving psoriasis, dermatomyositis, lupus erythematosus, and pemphigus vulgaris.  He is also active in a variety of national professional organizations and was recently chair of the finance committee for the American Society of Dermatopathology.
Education & Professional Highlights

Education & Professional Highlights

Appointed
2009

Education & Fellowships

Fellowship - Cleveland Clinic
Dermatopathology
Cleveland, OH USA
2011

Residency - University of Miami Hospitals and Clinics
Dermatology
Miami, FL USA
2009

Internship - Loyola University Medical Center
Internal Medicine
Maywood, IL USA
2006

Medical School - University of Illinois College of Medicine
Chicago, IL USA
2005

Doctorate - University of Illinois at Chicago
Chicago, IL USA
2003

Undergraduate - Northwestern University
Evanston, IL USA
1992

Professional Highlights

  • <p>Galimberti F, Li Y, <strong>Fernandez AP</strong>.&nbsp; <em>Clinicallyamyopathic dermatomyositis: clinical features, response to medications andmalignancy-associated risk factors in a specific tertiary-care-centre cohort</em>.&nbsp; Br J Dermatol 2015; epub ahead of print.&nbsp; PMID: 26490490.</p><p>Galimberti F, Li Y, <strong>FernandezAP</strong>. &nbsp;<em>Intravenousimmunoglobulin for treatment of dermatomyositis-associated dystrophiccalcinosis. </em>&nbsp;J Am Acad Dermatol&nbsp; 2015; 73(1):174-176.&nbsp; PMID: 26089058.</p><p><strong>Fernandez AP</strong>.&nbsp;<em>Dermatology Update:&nbsp; The Dawn of Targeted Therapy</em>.&nbsp; <span style="text-decoration: underline;">ClevClin J Med</span> 2015; 82(5): 309-320. PMID: 25973879.</p><p>Kinahan CE, Mazloom S, <strong>Fernandez,AP</strong>.&nbsp; <em>Impact of smoking on response to systemic treatment inpatients with psoriasis: a retrospective case-control study</em>.&nbsp; Br J Dermatol 2015; 172(2): 428-436.</p><p>Gonzalez E,Billings SD, <strong>Fernandez AP</strong>.&nbsp; <em>A refractory rash in a seborrheicdistribution</em>.&nbsp; Lancet2015; 385: 1777.&nbsp;</p><p>Kinahan CE, Mazloom S, <strong>Fernandez, AP</strong>.&nbsp; <em>Impact of smoking onresponse to systemic treatment in patients with psoriasis: a retrospective case-controlstudy</em>.&nbsp; <span style="text-decoration: underline;">Br J Dermatol</span> 2015; 172(2): 428-436.</p><p>Romero-Talam&aacute;s H, Aminian A, Corcelles R, Fernandez AP<span style="text-decoration: underline;">,</span> Schauer PR,Brethauer S.&nbsp; <em>Psoriasis Improvement After Bariatric Surgery. </em>SurgObes Rela Dis 2014; 10(6): 1155-1159. </p><p>Napekoski KM, <strong>Fernandez AP</strong>, Billings SD.&nbsp; <em>MicrovenularHemangioma: A clinicopathologic review of 13 cases</em>.&nbsp; J Cutan Pathol2014; 41(11): 816-22</p><p>Ko JS, Billings SD, Lanigan CP, Buehler D, <strong>Fernandez AP</strong>, Tubbs RR<em>.Fully Automated Dual-Color Dual-Hapten Silver In-Situ Hybridization Stainingfor MYC Amplification: a Diagnostic Tool for Discriminating SecondaryAngiosarcoma</em>. J Cut Pathol 2014; 41: 286-292.</p><p>Triozzi P, <strong>Fernandez AP</strong>.&nbsp; <em>The Role of the Immune Response inMerkel Cell Carcinoma</em>.&nbsp; <span style="text-decoration: underline;">Cancers</span> 2013; 5: 234-254.</p><p><strong>Fernandez AP</strong>, Wolfson A, Ahn E, Maldonado JC, Alonso-LlamazaresJ.&nbsp; <em>Kasabach-Merritt phenomenon in an adult man with a Tufted Angiomaarising in a Port-Wine-Stain and Hepatitis-C cirrhosis responding to electronbeam radiation, bevacizumab, and prednisone</em>.&nbsp; Int J Dermatol; 2014;53(9): 1165-1176.&nbsp; </p><p>Ko JS, <strong>Fernandez AP</strong>, Anderson KA, Burdick LM, Billings SD, Procop GW,McMahon JT, Bergfeld WF, Piliang MP.&nbsp; <em>Morphologic mimickers ofCryptococcus occurring within inflammatory infiltrates in the setting ofneutrophilic dermatitis: a series of three cases highlighting clinical dilemmasassociated with a novel histopathologic pitfall</em>.&nbsp; <span style="text-decoration: underline;">J Cut Pathol</span>2013; 40(1): 38-45.</p><p><strong>Fernandez AP</strong>, Sun Y, Tubbs R, Goldblum J, Billings SD. <em>FISH forMYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools inthe assessment of secondary angiosarcoma and atypical vascular proliferations.</em>J Cut Pathol 2011; In press. </p><p>Konda S, <strong>Fernandez AP</strong>, Berman B, Elgart G, Milikowski C,Alonso-Llamazares J. <em>Toxic epidermal necrolysis in the setting of systemiclupus erythematosus.</em> Int J Dermatol 2011; 50(10): 1270-1275. </p><p><strong>Fernandez AP</strong>, Miteva M, Roberts B, Rouhani P, Ricotti C, Romanelli P.<em>Histopathologic analysis of dermal lymphatic alterations in chronic venousinsufficiency ulcers using D2-40</em>. J Am Acad Dermatol 2011, 64: 1123.e1-12. </p><p><strong>Fernandez AP</strong>, Hu S, Kirsner RS. <em>Sirolimus: a potentialchemopreventive agent.</em> J Invest Dermatol 2008; 128(10): 2352. </p><p><strong>Fernandez AP</strong> and Kerdel FA. <em>The Use of IVIG therapy inDermatology.</em> Dermatologic Therapy, vol 20, #4 July/August 2007: 288-305. </p><p><strong>Fernandez AP</strong>, Piliang M, Bergfeld W. <em>The significant role ofcutaneous pathology for diagnosis of systemic lupus erythematosus in thesetting of chronic Hepatitis-C cirrhosis.</em> 47th Annual American Society ofDermatopathology meeting Program, Atlanta, GA, October 2010. </p><p><strong>Fernandez AP</strong>, Ricotti C, Nousari CH. <em>Increased mitotic rate oflesional histiocytes in multicentric reticulohistiocytosis is associated withunderlying malignancy.</em> 45th Annual American Society of Dermatopathologymeeting Program, San Francisco, CA, October 2008; page 131. </p><p><strong>Fernandez AP</strong>, Ricotti C, Nousari CH.<em> Proliferative multicentricreticulohistiocytosis associated with metastatic hepatocellular carcinoma.</em>45th Annual American Society of Dermatopathology meeting Program, SanFrancisco, CA, October 2008; page 87. </p><p><strong>Fernandez AP</strong>, Ricotti C, Nousari CH. <em>The spectrum of ofhistopathologic and immunopathologic findings in cutaneous lesions associatedwith dermatomyositis</em>. 45th Annual American Society of Dermatopathologymeeting Program, San Francisco, CA, October 2008; page 116. </p>

Certifications

  • Dermatology
  • Dermatology - Dermatopathology

Specialty Interests

Dermatomyositis, lupus, psoriasis, scleroderma, vasculitis, bullous pemphigoid, pemphigus, connective tissue diseases, cutaneous T-cell lymphoma, pyoderma gangrenosum, cutaneous ulcers, panniculitis, Sezary Syndrome

Awards & Honors

  • 2015 Finance Chair, ASDP
  • 2015 Caregiver Award; Cleveland Clinic
  • 2014 Director of Medical Dermatology; Cleveland Clinic, 2014 to Present
  • 2014 Financial Committee Chair, American Society of Dermatopathology
  • 2014 Teacher of the Year, Dermatopathology; Cleveland Clinic
  • 2013 Teacher of the Year, Clinical Dermatology, Cleveland Clinic
  • 2009 Miami Dermatological Society Resident&rsquo;s Research Day &ndash; 1st Place Award
  • 2009 Jaime Battan Compassionate Patient Care Award, University of Miami
  • 2006 Intern of the Year- Department of Internal Medicine, Loyola University
  • 2005 Association of Pathology Chairs Honor Society
  • 2004 Alpha Omega Alpha Honor Society
  • 2001 Sigma Xi Graduate Student Research Forum, UIC &ndash; Philip L. Hawley 1st Place Award

Memberships

  • Medical Dermatology Society
  • Rheumatologic Dermatology Society
  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
  • American Academy of Dermatology
  • The Myositis Association
  • The National Lupus Foundation
  • The Scleroderma Foundation
  • The Vasculitis Foundation
  • International Pemphigus Pemphigoid Foundation
  • National Psoriasis Foundation
  • American Society of Dermatopathology
Research & Publications

Research & Publications

See publications for Anthony Fernandez, MD, PhD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 11/21/2016, Dr. Fernandez has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Fernandez receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Celgene Corporation
  • Abbott Laboratories
  • Mallinckrodt, plc

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Patient Satisfaction Reviews

103 Patient Satisfaction Reviews

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.

Overall Star Ratings
4.8 out of 5
Explains 4.9
Listens 4.9
Courtesy, Respect & Concern 4.9
Knows Medical History 4.7
Time Spent with Patient 4.8
Patient Rating of Doctor 4.8

6 Patient Comments

Reviewed on Nov 9, 2016

Everything was A+. Would recommend Dr Fernandez to all my friends.

Reviewed on Nov 4, 2016

instructions were precise and clear

Reviewed on Jun 3, 2016

we LOVE coming here to see him. he is always pleasant, knowledgeable, kind, considerate, always gets my mothers medical issues back on the right road.I can not say enough praises about him and he s staff (in the back)

Reviewed on May 9, 2016

AWESOME!!

Reviewed on Apr 26, 2016

I thought I might have to switch meds b/c the price went up $200. Dr. Fernandez went over other options if we had to go that route. He also took the time to examine other parts of my skin that I was a little concerned about and told me everything looked fine.

Reviewed on Feb 3, 2016

Wonderful dr.

Related Videos